These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33312180)

  • 1. Corrigendum: The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage.
    Zhou JO; Zaidi HA; Ton T; Fera D
    Front Immunol; 2020; 11():620518. PubMed ID: 33312180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All eyes on the next generation of HIV vaccines: strategies for inducing a broadly neutralizing antibody response.
    Ahlers JD
    Discov Med; 2014 Apr; 17(94):187-99. PubMed ID: 24759623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses.
    Jeong BS; Jeon JY; Lai CJ; Yun HY; Jung JU; Oh BH
    Front Immunol; 2022; 13():1103893. PubMed ID: 36569833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.
    Sheng Z; Schramm CA; Connors M; Morris L; Mascola JR; Kwong PD; Shapiro L
    PLoS Comput Biol; 2016 May; 12(5):e1004940. PubMed ID: 27191167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immunodeficiency Virus Tat Protein Aids V Region Somatic Hypermutation in Human B Cells.
    Wang X; Duan Z; Yu G; Fan M; Scharff MD
    mBio; 2018 Apr; 9(2):. PubMed ID: 29666292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies.
    Ovchinnikov V; Louveau JE; Barton JP; Karplus M; Chakraborty AK
    Elife; 2018 Feb; 7():. PubMed ID: 29442996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Development of Foot-and-Mouth Disease Virus-Neutralizing Monoclonal Antibodies Derived From Plasmablasts of Infected Cattle and Their Germline Gene Usage.
    Li K; Wang S; Cao Y; Bao H; Li P; Sun P; Bai X; Fu Y; Ma X; Zhang J; Li D; Chen Y; Liu X; An F; Wu F; Lu Z; Liu Z
    Front Immunol; 2020; 11():286. PubMed ID: 32153589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage.
    Xu H; Schmidt AG; O'Donnell T; Therkelsen MD; Kepler TB; Moody MA; Haynes BF; Liao HX; Harrison SC; Shaw DE
    Proteins; 2015 Apr; 83(4):771-80. PubMed ID: 25524709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Expression of constitutive fusion of ubiquitin to PCNA restores the level of immunoglobulin A/T mutations during somatic hypermutation in the Ramos cell line.
    Lerner LK; Bonte D; Le Guillou M; Mohammad MM; Kasraian Z; Sarasin A; Despras E; Aoufouchi S
    Front Immunol; 2024; 15():1419493. PubMed ID: 38840919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
    Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to guide the antibody affinity maturation process.
    Doria-Rose NA; Joyce MG
    Curr Opin Virol; 2015 Apr; 11():137-47. PubMed ID: 25913818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.
    Wu X; Kong XP
    Curr Opin Immunol; 2016 Oct; 42():56-64. PubMed ID: 27289425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Higher Affinity Antibodies Bind With Lower Hydration and Flexibility in Large Scale Simulations.
    Wong MTY; Kelm S; Liu X; Taylor RD; Baker T; Essex JW
    Front Immunol; 2022; 13():969176. PubMed ID: 35860259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
    Bonsignori M; Zhou T; Sheng Z; Chen L; Gao F; Joyce MG; Ozorowski G; Chuang GY; Schramm CA; Wiehe K; Alam SM; Bradley T; Gladden MA; Hwang KK; Iyengar S; Kumar A; Lu X; Luo K; Mangiapani MC; Parks RJ; Song H; Acharya P; Bailer RT; Cao A; Druz A; Georgiev IS; Kwon YD; Louder MK; Zhang B; Zheng A; Hill BJ; Kong R; Soto C; ; Mullikin JC; Douek DC; Montefiori DC; Moody MA; Shaw GM; Hahn BH; Kelsoe G; Hraber PT; Korber BT; Boyd SD; Fire AZ; Kepler TB; Shapiro L; Ward AB; Mascola JR; Liao HX; Kwong PD; Haynes BF
    Cell; 2016 Apr; 165(2):449-63. PubMed ID: 26949186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.
    Hicar MD; Chen X; Kalams SA; Sojar H; Landucci G; Forthal DN; Spearman P; Crowe JE
    Mol Immunol; 2016 Feb; 70():94-103. PubMed ID: 26748387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Lessons from the Antibody Response to HIV-1.
    Victora GD; Mouquet H
    Cold Spring Harb Perspect Biol; 2018 May; 10(5):. PubMed ID: 28630079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
    Skinner NE; Ogega CO; Frumento N; Clark KE; Paul H; Yegnasubramanian S; Schuebel K; Meyers J; Gupta A; Wheelan S; Cox AL; Crowe JE; Ray SC; Bailey JR
    Front Immunol; 2023; 14():1201033. PubMed ID: 37180140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Model for Potential B-cell Precursors of Broadly Neutralizing HIV-1 Antibodies Selection and Antibody Affinity Maturation.
    Metlas R; Srdic-Rajic T
    AIDS Rev; 2019; 21(1):23-27. PubMed ID: 30899117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine.
    Zhou T; Xu K
    Adv Exp Med Biol; 2018; 1075():73-95. PubMed ID: 30030790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.
    Barbas CF; Hu D; Dunlop N; Sawyer L; Cababa D; Hendry RM; Nara PL; Burton DR
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3809-13. PubMed ID: 8170992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.